A practical model for economic evaluation of tissue-engineered therapies

Area of Science:

• Tissue engineering
• Regenerative medicine
• Biomedical engineering

Background:

• Tissue-engineered therapies are advancing rapidly, with some in clinical use and others in trials.
• Initial evaluations often prioritize clinical efficacy over economic factors.
• Economic competitiveness is a key determinant of therapeutic impact, often more so than clinical success.

Purpose of the Study:

• To highlight the importance of early economic viability assessment in tissue-engineered therapies.
• To introduce cost-minimization and sensitivity analysis as tools for economic evaluation.
• To demonstrate the practical application of economic modeling in tissue engineering.

Main Methods:

• Cost-minimization analysis
• Sensitivity analysis
• Case study: corneal endothelial transplantation

Main Results:

• Economic viability studies should be integrated early in the development pipeline.
• Cost-minimization and sensitivity analysis provide valuable data for investment decisions.
• Failure to address economic competitiveness can hinder the clinical impact of novel therapies.

Conclusions:

• Early economic evaluation is essential for the successful translation of tissue-engineered therapies.
• Cost-minimization analysis offers a robust framework for assessing economic viability.
• Integrating economic assessments early can optimize research and development investments.